University of Zurich
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1833-04-29
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uzh.ch
Effect of Acetazolamide on Exercise Performance in Patients With Respiratory Disease at Altitude
Phase 4
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2017-06-06
- Last Posted Date
- 2019-08-16
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 176
- Registration Number
- NCT03177837
- Locations
- 🇰🇬
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Cerebral Tissue Oxygenation in Highlanders/Lowlanders
Completed
- Conditions
- High Altitude Pulmonary Hypertension
- First Posted Date
- 2017-06-01
- Last Posted Date
- 2019-08-16
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 79
- Registration Number
- NCT03172429
- Locations
- 🇰🇬
National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Effect of Acetazolamide on Right Ventricular Function at Rest in Patients With Respiratory Disease at Altitude
Phase 4
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2017-06-01
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 110
- Registration Number
- NCT03173508
- Locations
- 🇰🇬
National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Differential Vascular and Endocrine Effects of Valsartan/Sacubitril in Heart Failure With Reduced Ejection Fraction
Phase 4
Completed
- Conditions
- Heart Failure
- Interventions
- Drug: Valsartan/Sacubitril or placebo
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 79
- Registration Number
- NCT03168568
- Locations
- 🇨🇭
University Heart Center Zurich, Zurich, Switzerland
Effect of Acetazolamide on Right Ventricular Function During Exercise in Patients With Respiratory Disease at Altitude
Phase 4
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 110
- Registration Number
- NCT03167034
- Locations
- 🇰🇬
National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.
Completed
- Conditions
- Sleep ApneaHigh Altitude Pulmonary Hypertension
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2019-08-16
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 165
- Registration Number
- NCT03165019
- Locations
- 🇰🇬
National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Effect of Acetazolamide on Cognition in Patients With Respiratory Disease at Altitude
Phase 4
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 78
- Registration Number
- NCT03165890
- Locations
- 🇰🇬
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Right Ventricular Function at Rest in Highlanders/Lowlanders
Completed
- Conditions
- High Altitude Pulmonary Hypertension
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2019-08-16
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 173
- Registration Number
- NCT03165656
- Locations
- 🇰🇬
National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Right Ventricular Function During Exercise in Highlanders/Lowlanders
Completed
- Conditions
- High Altitude Pulmonary Hypertension
- First Posted Date
- 2017-05-24
- Last Posted Date
- 2019-08-16
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 173
- Registration Number
- NCT03165032
- Locations
- 🇰🇬
National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
Completed
- Conditions
- Early PregnancyFertility Disorders
- Interventions
- Device: Ava
- First Posted Date
- 2017-05-22
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 194
- Registration Number
- NCT03161873
- Locations
- 🇨🇭
Clinic for Reproductive Endocrinology, Zürich, Switzerland
© Copyright 2025. All Rights Reserved by MedPath